ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,308.13
      0.09%
      US Tech 100
      18,176.80
      0.59%
      Dow Jones
      39,806.77
      -0.49%
      Brent Oil
      83.515
      -0.10%
      Bitcoin
      69,318.77
      4.59%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Maxpro Capital Acquisition Corporation (JMACU)

      7. Maxpro Capital Acquisition Corporation (JMACU) News

      JMACU

      Maxpro Capital Acquisition (JMACU)

      Maxpro Capital Acquisition Corporation
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:JMACU
      DateTimeSourceHeadlineSymbolCompany
      04/10/20239:01AMEdgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)NASDAQ:JMACUMaxpro Capital Acquisition Corporation
      03/31/20234:01PMEdgar (US Regulatory)Annual Report (10-k)NASDAQ:JMACUMaxpro Capital Acquisition Corporation
      03/30/20238:10AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:JMACUMaxpro Capital Acquisition Corporation
      03/29/20235:37PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:JMACUMaxpro Capital Acquisition Corporation
      03/29/20235:13PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:JMACUMaxpro Capital Acquisition Corporation
      03/29/20234:25PMEdgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:JMACUMaxpro Capital Acquisition Corporation
      03/29/20234:24PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:JMACUMaxpro Capital Acquisition Corporation
      03/21/20234:08PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:JMACUMaxpro Capital Acquisition Corporation
      02/14/20234:56PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:JMACUMaxpro Capital Acquisition Corporation
      02/13/20234:08PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:JMACUMaxpro Capital Acquisition Corporation
      02/10/20237:08AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:JMACUMaxpro Capital Acquisition Corporation
      01/13/20234:34PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:JMACUMaxpro Capital Acquisition Corporation
      01/13/20234:13PMGlobeNewswire Inc.Maxpro Capital Acquisition Corp. Confirms Additional Funding and Extension of Deadline to Complete Initial Business CombinationNASDAQ:JMACUMaxpro Capital Acquisition Corporation
      01/10/20234:32PMEdgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:JMACUMaxpro Capital Acquisition Corporation
      01/10/20234:24PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:JMACUMaxpro Capital Acquisition Corporation
      01/10/20234:05PMGlobeNewswire Inc.Maxpro Capital Acquisition Corp. Announces Extension to Deadline to Complete Business CombinationNASDAQ:JMACUMaxpro Capital Acquisition Corporation
      11/15/20228:00AMGlobeNewswire Inc.Apollomics Inc. Receives FDA Orphan Drug Designation for Vebreltinib (APL-101) for Treatment of Non-Small Cell Lung Cancer with MET Genomic Tumor AberrationsNASDAQ:JMACUMaxpro Capital Acquisition Corporation
      10/14/20224:59PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:JMACUMaxpro Capital Acquisition Corporation
      10/14/20224:54PMGlobeNewswire Inc.Maxpro Capital Acquisition Corp. Confirms Additional Funding and Extension of Deadline to Complete Initial Business CombinationNASDAQ:JMACUMaxpro Capital Acquisition Corporation
      10/07/20224:22PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:JMACUMaxpro Capital Acquisition Corporation
      10/07/20224:05PMGlobeNewswire Inc.Maxpro Capital Acquisition Corp. Announces Extension to Deadline to Complete Business CombinationNASDAQ:JMACUMaxpro Capital Acquisition Corporation
      09/15/20226:22AMEdgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:JMACUMaxpro Capital Acquisition Corporation
      09/14/202212:04PMEdgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:JMACUMaxpro Capital Acquisition Corporation
      09/14/202212:04PMEdgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:JMACUMaxpro Capital Acquisition Corporation
      09/14/202212:03PMEdgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:JMACUMaxpro Capital Acquisition Corporation
      09/14/20228:32AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:JMACUMaxpro Capital Acquisition Corporation
      09/14/20228:30AMGlobeNewswire Inc.Apollomics Inc., a Late-Stage Clinical Biopharmaceutical Company to be Listed on Nasdaq Through Business Combination with Maxpro Capital Acquisition Corp.NASDAQ:JMACUMaxpro Capital Acquisition Corporation
      02/14/20224:15PMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:JMACUMaxpro Capital Acquisition Corporation
      01/13/20224:06PMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:JMACUMaxpro Capital Acquisition Corporation
      11/26/20219:25AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:JMACUMaxpro Capital Acquisition Corporation
       Showing the most relevant articles for your search:NASDAQ:JMACU